XML 31 R18.htm IDEA: XBRL DOCUMENT
v3.20.2

REVENUES (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2020
REVENUES |
Schedule of Company's disaggregation of revenues | The following table summarizes the Company’s disaggregation of revenues: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Nine Months Ended September 30, | ​
(U.S. dollars in thousands) |  | 2020 |  | 2019 | ​
Pfizer | ​ | $ | 5,844 | ​ | $ | 4,701 | ​
Brazil | ​ | $ | 6,000 | ​ | $ | 7,385 | ​
Chiesi | ​ | $ | 131 | ​ | $ | — | ​
Total revenues from selling goods | ​ | $ | 11,975 | ​ | $ | 12,086 | ​
Revenues from license and R&D services | ​ | $ | 31,428 | ​ | $ | 24,848 | ​

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueRecognitionAndDeferredRevenueAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration